High-sensitivity CRP may be a marker of HDL dysfunction and remodeling in patients with acute coronary syndrome

Xiaoyu Tang1, Ling Mao1, Jin Chen1

  • 1Department of Cardiovascular Medicine, Research Institute of Blood Lipids and Atherosclerosis, The Second Xiangya Hospital of Central South University, No. 139 Middle Renmin Road, Changsha, 410011, Hunan, China.

Scientific Reports
|June 2, 2021
PubMed

Insights

High-density lipoprotein cholesterol (HDL-C) levels do not reflect HDL function in coronary artery disease (CAD) patients. Inflammation marker high-sensitivity C-reactive protein (hsCRP) may indicate impaired cholesterol efflux capacity (CEC) in acute coronary syndrome.

Area of Science:

  • Cardiovascular Medicine
  • Biochemistry
  • Medical Diagnostics

Background:

  • High-density lipoprotein cholesterol (HDL-C) levels are a traditional cardiovascular risk marker.
  • Increasing HDL-C has not consistently reduced cardiovascular risk in patients with coronary artery disease (CAD).
  • Cholesterol efflux capacity (CEC), a measure of HDL function, may be a better predictor of CAD risk than HDL-C, but its measurement is complex.

Purpose of the Study:

  • To explore an easily acquired index for evaluating CEC in CAD patients.
  • To investigate the relationship between HDL components, CEC, and inflammation markers in CAD.
  • To determine if HDL-C levels reflect HDL function in patients with acute coronary syndrome (ACS).

Main Methods:

  • Cross-sectional study of 36 CAD patients (all with ACS) and 61 controls.
  • CEC measured using a [3H] cholesterol loading cell model with apolipoprotein B-depleted plasma.
  • HDL components and subclass distribution assessed using proton nuclear magnetic resonance (NMR) spectroscopy.

Main Results:

  • CEC was significantly lower in CAD patients compared to controls (p=0.022).
  • In CAD patients, CEC did not correlate with HDL-C or NMR-determined HDL-C.
  • High-sensitivity C-reactive protein (hsCRP) was inversely associated with CEC (r=-0.351, p=0.036) in CAD patients.
  • NMR showed larger HDL particles in patients with high hsCRP, accompanied by decreased CEC.

Conclusions:

  • In CAD patients, HDL-C levels do not accurately reflect HDL's cholesterol efflux function.
  • Inflammation, indicated by hsCRP, may lead to HDL subclass remodeling and dysfunction in ACS.
  • hsCRP may serve as a potential indicator of HDL dysfunction in ACS, warranting further investigation.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
287
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
62
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
184
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
207
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
473
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
104